Use for the treatment and prevention of atherosclerosis protein-peptide complex (hereinafter BOD) derived from the embryonic neural tissue or quick-frozen fetal brain agricultural ungulates affecting the reverse transport of cholesterol from the vessel wall and the profile of the activation of monocytes in patients with severe atherosclerosis main vessels or with a predisposition to cardiovascular disease and a method of prevention and treatment of patients with atherosclerosis and arterial disease caused by atherosclerosis of the main and peripheral vessels of the brain, heart, blood vessels of the lower extremities and the aorta (two options)

摘要

1. The use for the treatment and prevention of atherosclerosis protein-peptide complex (hereinafter - BOD) derived from fetal nervous tissue or from a fetal brain quick-frozen agricultural ungulates affecting the reverse transport of cholesterol from the vessel wall and the profile of the activation of monocytes in patients with severe atherosclerosis backbone vessels or predisposed to cardiovascular disease, including negatively charged, neutral proteins and polypeptides, with molecular weights from 0.5 to 200 kDa or in conjunction with it polynucleotides as Na-salt of DNA isolated from sturgeon milt or salmon fish, in the form of protein-polynucleotide-peptide complex for the prophylaxis and treatment of patients with atherosclerosis and arterial disease, caused by atherosclerosis of the main and peripheral vessels of the brain, heart, blood vessels of the lower extremities, and aortic administered in a therapeutically effective daily and course doses administered parenterally or intranasally, and regulating cholesterol metabolism, cholesteryl ester, triglycerides, phospholipids subendothelial connective tissue and smooth muscle cells of arterial sosudov.2. A method for preventing and treating atherosclerotic patients arterial vessels and diseases caused by atherosclerosis main and peripheral vessels of the brain, heart, blood vessels of the lower limbs and the aorta, comprising administering to a patient a pharmaceutical preparation comprising a protein-peptide complex (hereinafter - BOD) in combination with a pharmaceutically acceptable carrier or parenterally intro